The Fragile X Protein Disordered Regions Bind a Novel RNA Target

Area of Science:

• Molecular Biology
• Neuroscience
• Genetics

Background:

• Fragile X proteins (FXPs) regulate mRNA translation, essential for neural development and cognition.
• Absence of fragile X mental retardation protein (FMRP) causes fragile X syndrome (FXS), a leading genetic cause of autism spectrum disorders.
• Identifying FXP mRNA targets is key for understanding FXS and developing therapeutics.

Purpose of the Study:

• To identify novel RNA targets of FXPs beyond known G-quadruplex structures.
• To characterize the binding interaction between FXPs and a specific non-G-quadruplex RNA.
• To determine the FMRP domains responsible for binding this RNA target.

Main Methods:

• In vitro RNA binding assays to determine equilibrium constants.
• RNA pull-down techniques to identify mRNA targets.
• Biochemical analysis to map the FMRP binding domain.

Main Results:

• A 99-nucleotide RNA target was identified and shown to be bound by all three FXPs with nanomolar affinity.
• The C-terminal 102 amino acids of FMRP, including the RGG motif, were found to be necessary and sufficient for binding this RNA.
• This represents a rare example of RGG motif-mediated binding to a non-G-quadruplex, non-homopolymer RNA.

Conclusions:

• FXPs bind specific non-G-quadruplex RNA structures.
• The RGG motif and C-terminus of FMRP play a critical role in RNA recognition.
• These findings expand the known repertoire of FXP-RNA interactions and offer potential therapeutic targets for FXS.